Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Announces Second Quarter 2023 Financial Results
09 August 2023 - 6:00AM
BYND Cannasoft Enterprises Inc. (Nasdaq:
BCAN,
CSE:
BYND) (“
BYND” or the
“
Company”) has released its financial results for
the six-month period ended June 30, 2023. Full versions of BYND's
unaudited consolidated interim financial statements and management
discussion and analysis for the period can be found on
www.sedar.com.
Q2 2023 Financial
Highlights:
- Revenue increased 21% to $251,047 in Q2 2023 from $207,653 in
Q2 2022.
- Gross Profit decreased to 57% for the six-month period ended
June 30, 2023, from 59% in 2022.
- Net loss increased 242% to $1,147,324 in Q2 2023 from $473,386
in Q2 2022.
- Working capital decreased to 1,021,170 on June 30, 2023, from
$2,987,975 on December 31, 2022.
- Total assets decreased to $47,946,377 for June 30, 2023, from
$49,903,208 for December 31, 2022.
- The total shares outstanding as of June 30, 2023, were
37,899,386.
Summary of Quarterly Comparison of
Revenue, Gross Profit and Net Loss
|
Q2 2023 |
Q1 2023 |
Q4 2022 |
Q3 2022 |
Q2 2022 |
Q1 2022 |
Q4 2021 |
Revenue |
251,047 |
$420,635 |
$232,186 |
$227,954 |
$207,653 |
$455,279 |
$258,303 |
Gross Profit |
66,239 |
$316,943 |
$96,938 |
$126,866 |
$37,657 |
$355,111 |
$149,080 |
Net Loss |
(1,147,324) |
$(740,433) |
$(700,222) |
$(325,793) |
$(473,386) |
$(165,283) |
$(318,368) |
Mr. Yftah Ben Yaackov, BYND's CEO, noted, "We
are very pleased with the Company's financial results during Q2 of
2023 as we were able to increase revenues while investing in our
future products. With the proceeds from the recent public offering,
we are able to continue investing in our patent registrations and
the creation of the EZ-G prototype, and we plan to introduce the
products to the market before the end of 2023."
Despite the decline in gross profit percentage,
the Company remains focused on its long-term growth strategy and
product development initiatives. The net loss for Q2 2023 increased
significantly compared to the same period last year. This can be
attributed to the strategic investments made by the Company to fuel
its growth and innovation. These investments are part of a
well-defined plan to bring new products to the market, enhancing
BYND's position as a pioneer in the sexual wellness industry.
The decrease in working capital and total assets
is a result of planned expenditures and investments for the
development of new products and the enhancement of existing ones.
The Company remains well-capitalized to support its growth and
expansion plans.
Investors and stakeholders are encouraged to
review the complete consolidated interim financial statements and
management discussion and analysis for deeper insights into BYND's
financial performance during Q2 2023. BYND believes in its
long-term strategy and the positive impact it will have on the
Company's growth and profitability as they continue to focus on
expanding its patent portfolio and advancing product
development.
About BYND Cannasoft Enterprises
Inc.
BYND Cannasoft Enterprises is an Israeli-based
integrated software and cannabis company. BYND Cannasoft owns and
markets "Benefit CRM," a proprietary customer relationship
management (CRM) software product enabling small and medium‐sized
businesses to optimize their day‐to‐day business activities such as
sales management, personnel management, marketing, call center
activities, and asset management. Building on our 20 years of
experience in CRM software, BYND Cannasoft is developing an
innovative new CRM platform to serve the needs of the medical
cannabis industry by making it a more organized, accessible, and
price-transparent market. The Cannabis CRM System will include a
Job Management (BENEFIT) and a module system (CANNASOFT) for
managing farms and greenhouses with varied crops. BYND Cannasoft
owns the patent-pending intellectual property for the EZ-G device.
This therapeutic device uses proprietary software to regulate the
flow of low concentrations of CBD oil, hemp seed oil, and other
natural oils into the soft tissues of the female reproductive
system to potentially treat a wide variety of women's health
issues. The EZ-G device includes technological advancements as a
sex toy with a more realistic experience and the prototype utilizes
sensors to determine what enhances the users' pleasure. The user
can control the device through a Bluetooth app installed on a
smartphone or other portable device. The data will be transmitted
and received from the device to and from the secure cloud using
artificial intelligence (AI). The data is combined with other
antonymic user preferences to improve its operation by increasing
sexual satisfaction.
For Further Information, please refer to
information available on the Company’s website:
www.cannasoft-crm.com, the CSE’s website:
www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc
and on SEDAR: www.sedar.com.
Gabi KabazoChief Financial OfficerTel: (604)
833-6820e‐mail: ir@cannasoft-crm.com
For Media and Investor Relations, please
contact:
David L. Kugelman(866) 692-6847 Toll Free - U.S.
& Canada(404) 281-8556 Mobile and WhatsAppdk@atlcp.comSkype:
kugsusa
Cautionary Note Regarding
Forward-Looking Statements
This press release includes certain statements that may be
deemed “forward-looking statements”. All statements in this
release, other than statements of historical facts, that address
future events or developments that the Company expects, are
forward-looking statements. Although the Company believes the
expectations expressed in such forward-looking statements are based
on reasonable assumptions, such statements are not guarantees of
future performance, and actual events or developments may differ
materially from those in forward-looking statements. Such
forward-looking statements necessarily involve known and unknown
risks and uncertainties, which may cause the Company’s actual
performance and financial results in future periods to differ
materially from any projections of future performance or results
expressed or implied by such forward-looking statements. Such
statements reflect the Company's current views with respect to
future events and are subject to such risks and uncertainties. Many
factors could cause actual results to differ materially from the
statements made, including future financial performance,
unanticipated regulatory requests and delays, final patents
approval, and those factors discussed in filings made by the
company with the Canadian securities regulatory authorities,
including (without limitation) in the company's management's
discussion and analysis for the year ended December 31, 2022 and
annual information form dated March 31, 2023, which are available
under the company's profile at www.sedar.com, and in the Company’s
Annual Report on Form 20-F for the year then ended that was filed
with the U.S. Securities and Exchange Commission on April 27, 2023.
Should one or more of these factors occur, or should assumptions
underlying the forward-looking statements prove incorrect, actual
results may vary materially from those described herein as
intended, planned, anticipated, or expected. We do not intend and
do not assume any obligation to update these forward‐looking
statements, except as required by law. Any such forward-looking
statements represent management's estimates as of the date of this
press release. While we may elect to update such forward-looking
statements at some point in the future, we disclaim any obligation
to do so, even if subsequent events cause our views to change.
Shareholders are cautioned not to put undue reliance on such
forward‐looking statements.
Femto Technologies (NASDAQ:BCAN)
Historical Stock Chart
From Nov 2024 to Dec 2024
Femto Technologies (NASDAQ:BCAN)
Historical Stock Chart
From Dec 2023 to Dec 2024